• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Animal Model Exp Med . Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models

tetano

Editor, Senior Moderator
Animal Model Exp Med


. 2025 May 20.
doi: 10.1002/ame2.70029. Online ahead of print. Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models

Qi Lv[SUP] 1 2 [/SUP], Ming Liu[SUP] 1 [/SUP], Feifei Qi[SUP] 1 2 [/SUP], Mingya Liu[SUP] 1 [/SUP], Fengdi Li[SUP] 1 2 [/SUP], Ran Deng[SUP] 1 2 [/SUP], Xujian Liang[SUP] 1 2 [/SUP], Yanfeng Xu[SUP] 1 2 [/SUP], Zhiqi Song[SUP] 1 2 [/SUP], Yiwei Yan[SUP] 1 [/SUP], Shuyue Li[SUP] 1 [/SUP], Guocui Mou[SUP] 1 [/SUP], Linlin Bao[SUP] 1 2 3 [/SUP]



Affiliations
Free article Abstract

Background: New variants of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)continue to drive global epidemics and pose significant health risks. The pathogenicity of these variants evolves under immune pressure and host factors. Understanding these changes is crucial for epidemic control and variant research.
Methods: Human angiotensin-converting enzyme 2(hACE2) transgenic mice were intranasally challenged with the original strain WH-09 and the variants Delta, Beta, and Omicron BA.1, while BALB/c mice were challenged with Omicron subvariants BA.5, BF.7, and XBB.1. To compare the pathogenicity differences among variants, we conducted a comprehensive analysis that included clinical symptom observation, measurement of viral loads in the trachea and lungs, evaluation of pulmonary pathology, analysis of immune cell infiltration, and quantification of cytokine levels.
Results: In hACE2 mice, the Beta variant caused significant weight loss, severe lung inflammation, increased inflammatory and chemotactic factor secretion, greater macrophage and neutrophil infiltration in the lungs, and higher viral loads with prolonged shedding duration. In contrast, BA.1 showed a significant reduction in pathogenicity. The BA.5, BF.7, and XBB.1 variants were less pathogenic than the WH-09, Beta, and Delta variants when infected in BALB/c mice. This was evidenced by reduced weight loss, diminished pulmonary pathology, decreased secretion of inflammatory factors and chemokines, reduced macrophage and neutrophil infiltration, as well as lower viral loads in both the trachea and lungs.
Conclusion: In hACE2 mice, the Omicron variant demonstrated the lowest pathogenicity, while the Beta variant exhibited the highest. Pathogenicity of the Delta variant was comparable to the original WH-09 strain. Among BALB/c mice, Omicron subvariants BA.5, BF.7, and XBB.1 showed no statistically significant differences in virulence.

Keywords: SARS‐CoV‐2; mice model; pathogenicity; variants.

 
Back
Top Bottom